Who We Are

HMR launches new website for Japanese bridging studies

Bridging studies are clinical trials to compare the safety and effects of IMPs in different ethnic groups, and can help sponsors get earlier approval for their IMPs in Japan. Our Japanese-speaking staff have up to 10 years' experience of bridging studies. We've done:

  • bioequivalence studies of new products not yet marketed in Japan;

  • studies that can't be done in Japan, such as studies of opioid drugs;

  • studies with 'add-on' cohorts of Japanese subjects for large, complex, first-in-man single- and repeat-dose trials in Caucasians; and

  • comparative studies in Caucasian, Japanese, Chinese and Korean subjects.

Visit our bridging studies website.

Back to list
National Training AwardsCyber EssentialsDigital XRaidA proud member of UK BioIndustry Associationone nucleus